White PaperMay 2026
External Control Arms: A 2026 Regulatory Playbook
How FDA and EMA are evaluating RWE-derived external controls — and what sponsors should prepare.
Read moreInsights
Perspectives from our scientific team
Research, frameworks, and field notes on evidence generation in modern life sciences.
ArticleApr 2026
LLMs in Clinical Abstraction: Where Accuracy Meets Auditability
Lessons from deploying clinical-grade language models across oncology cohorts.
Read moreWebinarMar 2026
Building Payer-Ready Evidence for Cell & Gene Therapies
Strategies for durability evidence, outcomes-based contracts, and HTA submissions.
Read moreArticleFeb 2026
From Cohort to Conclusion in 30 Days
A look inside the Elevora Study OS and how we compress timelines without compromising rigor.
Read morePerspectiveJan 2026
The Federated Future of Real-World Data
Why bringing the model to the data — not the other way around — will define the next decade.
Read moreCase NoteDec 2025
Rare Disease Natural History: A Practical Framework
Patient identification, longitudinal capture, and regulatory engagement for ultra-rare programs.
Read more